Insurance giant, seizing on Trump initiative, will require Medicare beneficiaries to try controversial ‘step therapy’
One of the nation’s largest health insurers will use “step therapy” in some of its private Medicare plans next year, requiring patients to try cheaper drugs before pricey biologics and other costly medicines.
